| 國立成功大學 |
2020-04-1 |
In vitro activity of ceftazidime-avibactam and comparators against Gram-negative bacterial isolates collected in the Asia-Pacific region as part of the INFORM program (2015-2017)
|
Ko;Wen-Chien;Stone;Gregory, Gregory G. |
| 國立成功大學 |
2018 |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Jean, S.-S.;Lu, M.-C.;Shi, Z.-Y.;Tseng, S.-H.;Wu, T.-S.;Lu, P.-L.;Shao, P.-L.;Ko, W.-C.;Wang, F.-D.;Hsueh, P.-R. |
| 臺大學術典藏 |
2020-03-27T05:28:35Z |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
PO-REN HSUEH;Wang F.-D.;Ko W.-C.;Shao P.-L.;Lu P.-L.;Wu T.-S.;Tseng S.-H.;Shi Z.-Y.;Lu M.-C.;Jean S.-S.; Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; Shao P.-L.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH |
| 臺大學術典藏 |
2021-05-06T08:25:58Z |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; PEI-LAN SHAO; Ko W.-C.; Wang F.-D.; Hsueh P.-R. |
| 臺大學術典藏 |
2020-12-18T08:37:10Z |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Jean S.-S.;Lu M.-C.;Shi Z.-Y.;Tseng S.-H.;Wu T.-S.;Lu P.-L.;Shao P.-L.;Ko W.-C.;Wang F.-D.;Po-Ren Hsueh; Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; Shao P.-L.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH |
| 臺北醫學大學 |
1998 |
In vitro activity of ciprofloxacin against Mycobacterium tuberculosis
|
白冠壬; Ming-Chih Yu; Tzong-Fei Ong; Jen Suo; Kuan-Jen Bai; Tao-Ping Lin |
| 嘉南藥理大學 |
2015 |
In Vitro Activity of Imipenem and Colistin against a Carbapenem-Resistant Klebsiella pneumoniae Isolate Coproducing SHV-31, CMY-2, and DHA-1
|
Tang, Hung-Jen; Ku, Yee-Huang; Lee, Mei-Feng; Chuang, Yin-Ching; Yu, Wen-Liang |
| 國立成功大學 |
2023 |
In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales causing urinary tract infection in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2020
|
Chang, Chang C.-Y.;Lee, Y.-L.;Huang, Y.-T.;Ko, W.-C.;Ho, M.-W.;Hsueh, P.-R. |
| 國立成功大學 |
2023 |
In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales from patients with intra-abdominal infections: Results of the study for Monitoring Antimicrobial Resistance Trends (SMART) in Taiwan, 2020
|
Lee, Y.-L.;Ko, W.-C.;Hsueh, P.-R. |
| 國立成功大學 |
2023 |
In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Pseudomonas aeruginosa in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) in 2020
|
Liu, Y.-M.;Ko, W.-C.;Ho, M.-W.;Lee, Y.-L.;Hsueh, P.-R. |
| 國家衛生研究院 |
2021-05-06 |
In vitro activity of imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan
|
Kuo, SC;Wang, YC;Tan, MC;Huang, WC;Shiau, YR;Wang, HY;Lai, JF;Huang, IW;Lauderdale, TL |
| 高雄醫學大學 |
2009 |
In vitro Activity of Impatiens balsamina L. Against Multiple Antibiotic-Resistant Helicobacter pylori.
|
王苑春;吳登強;廖俊吉;吳政勳;李婉瑜;翁碧娟 ; Yuan-Chuen Wang;Deng-Chang Wu;Jyun-Ji Liao;Cheng-Hsun Wu;Wan-Yu Li;Bi-Chuang Weng |
| 臺大學術典藏 |
2018-09-10T06:16:32Z |
In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections
|
Tsai, T.-Y. and Chang, S.-C. and Hsueh, P.-R. and Feng, N.-H. and Wang, J.-T.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-03-27T05:30:23Z |
In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections
|
Wang J.-T.;Feng N.-H.;PO-REN HSUEH;Chang S.-C.;Tsai T.-Y.; Tsai T.-Y.; Chang S.-C.; PO-REN HSUEH; Feng N.-H.; Wang J.-T. |
| 臺大學術典藏 |
2020-12-29T03:09:20Z |
In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections
|
Chang S.-C.; Hsueh P.-R.; Feng N.-H.; JANN-TAY WANG; Tsai T.-Y.;Chang S.-C.;Hsueh P.-R.;Feng N.-H.;Jann-Tay Wang; Tsai T.-Y. |
| 臺大學術典藏 |
2020-12-18T08:39:13Z |
In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections
|
Tsai T.-Y.; Chang S.-C.; PO-REN HSUEH; Feng N.-H.; Wang J.-T. |
| 臺大學術典藏 |
2022-05-13T08:05:05Z |
In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections
|
Tsai T.-Y.; Chang S.-C.; Hsueh P.-R.; Feng N.-H.; JANN-TAY WANG |
| 臺大學術典藏 |
2018-09-10T03:40:52Z |
In vitro activity of linezolid against clinical Gram-positive bacterial isolates from Taiwan: An area with a high prevalence of antibiotic resistance
|
Fang, C.-T. and Chang, S.-C. and Chen, Y.-C. and Hsieh, S.-M. and Hsieh, W.-C.; SZU-MIN HSIEH; CHI-TAI FANG; SHAN-CHWEN CHANG; YEE-CHUN CHEN |
| 國立臺灣大學 |
2001 |
In vitro activity of linezolid against clinical Gram-positive bacterial isolates from Taiwan: an area with a high prevalence of antibiotic resistance
|
Fang, Chi?Tai; Chang, Shan-Chwen; Chen, Yee-Chun; Hsieh, Szu-Min; Hsieh, Wei-Chuan |
| 國立臺灣大學 |
2001 |
In Vitro Activity of Linezolid against Clinical Gram-Positive Bacterial Isolates from Taiwan: An Area with a High Prevalence of Antibiotic Resistance
|
方啟泰; 張上淳; 陳宜君; 謝思民; 謝維銓; FANG, CHI-TAI; CHANG, SHAN-CHWEN; CHEN, YEE-CHUN; HSIEH, SZU-MIN; HSIEH WEI-CHUAN |
| 臺大學術典藏 |
2020-09-29T01:48:20Z |
In vitro activity of linezolid against clinical Gram-positive bacterial isolates from Taiwan: An area with a high prevalence of antibiotic resistance
|
Fang C.-T.;Chang S.-C.;Yee-Chun Chen;Hsieh S.-M.;Hsieh W.-C.; Fang C.-T.; Chang S.-C.; YEE-CHUN CHEN; Hsieh S.-M.; Hsieh W.-C. |
| 臺大學術典藏 |
2020-12-29T06:37:25Z |
In vitro activity of linezolid against clinical Gram-positive bacterial isolates from Taiwan: An area with a high prevalence of antibiotic resistance
|
Fang C.-T.; Chang S.-C.; Fang C.-T.;Chang S.-C.;Chen Y.-C.;Szu-Min Hsieh;Hsieh W.-C.; Chen Y.-C.; SZU-MIN HSIEH; Hsieh W.-C. |
| 臺大學術典藏 |
2020-12-30T02:43:37Z |
In vitro activity of linezolid against clinical Gram-positive bacterial isolates from Taiwan: An area with a high prevalence of antibiotic resistance
|
Hsieh S.-M.; Chen Y.-C.; SHAN-CHWEN CHANG; Fang C.-T.; Fang C.-T.;Shan-Chwen Chang;Chen Y.-C.;Hsieh S.-M.;Hsieh W.-C.; Hsieh W.-C. |
| 臺大學術典藏 |
2021-05-06T01:53:05Z |
In vitro activity of linezolid against clinical Gram-positive bacterial isolates from Taiwan: An area with a high prevalence of antibiotic resistance
|
Fang C.-T.; Chang S.-C.; YEE-CHUN CHEN; Hsieh S.-M.; Hsieh W.-C. |
| 臺大學術典藏 |
2021-04-20T03:46:31Z |
In vitro activity of linezolid against clinical Gram-positive bacterial isolates from Taiwan: An area with a high prevalence of antibiotic resistance
|
CHI-TAI FANG; Chang S.-C.; Chen Y.-C.; Hsieh S.-M.; Hsieh W.-C. |
